Cephalon, Inc. today announced that it has filed a lawsuit in U.S. District Court in Delaware against Teva Pharmaceuticals USA, Inc. for infringement of U.S. Patent Nos. 7,132,570, 7,297,346 (the "'346 Patent") and RE37,516 (for the Cephalon product NUVIGIL® (armodafinil) Tablets [C-IV].
The details can be read here.
No comments:
Post a Comment